Media release
From:
Journal/
conference: Respirology
conference: Respirology
Research:Paper
Organisation/s:
Macquarie University, The University of New South Wales, The University of Sydney
Funder:
The Australian Centre for Airways disease Monitoring
(ACAM) is a unit of the Woolcock Institute of Medical
Research, an independent medical research institute. ACAM
is funded from a range of sources including investigatorinitiated
research grants funded by industry partners including
GlaxoSmithKline, AstraZeneca and Novartis.
Support for the present manuscript was provided via
funding paid to the institution from the National Health
and Medical Research Council Centre for Research
Excellence. Research Grants have also been received by the
institution from AstraZeneca, Glaxo Smith Kline and Perpetual
Philanthropy.